492 computer-programmer "https:" "https:" "https:" "https:" positions at University of Colorado
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
with expertise in limb reconstruction, limb salvage, deformity correction, nonunion surgery, and bone infection to serve as the next Director of the University of Colorado Limb Restoration Program. This
-
and conducts world-renowned research fueled by over $757 million in research grants. For more information, visit www.cuanschutz.edu . The Division of Hematology, Blood Cancer and BMT Program has
-
Advanced Practice Provider (APP) Breast Oncology Program/(PA/NP)/Medicine/Medical Oncology/Instructor of Clinical Practice - 41053 Faculty Description University of Colorado Anschutz Department
-
are seeking a vision scientist to fill an open-rank, tenure-eligible faculty position. The ideal candidate will be an outstanding individual whose research program includes mechanistic investigation
-
contributions that add to your bottom line. Benefits: https://www.cu.edu/employee-services/benefits Total Compensation Calculator: http://www.cu.edu/node/153125 Application Deadline Application deadline is
-
. The position provides strategic leadership for graduate education policy, program quality and innovation, graduate enrollment and student success, graduate student support and funding, and the integration
-
. The University of Colorado provides generous leave, health plans and retirement contributions that add to your bottom line. Total Compensation Calculator: http://www.cu.edu/node/153125 Equal Employment Opportunity
-
. This psychologist will be dedicated to improving care for patients served in the Medical Day Treatment Program (.8) and in the Outpatient Medical Complexity Specialty Program (.2) at CHCO. The Medical Day Treatment
-
of Colorado’s APP Fellowship in Child in Adolescent Psychiatry is an optional, post-licensure training program for new graduate PMHNPs interested in advanced training in the subspecialty of child and adolescent
-
pharmacology, preclinical oncology, and mouse therapeutic efficacy studies to contribute to a federally funded translational research program focused on the preclinical development of novel small-molecule